Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. TEVA
  6. >
  7. Forecast
stocks logo

TEVA Stock Price Prediction

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

Should I Buy Teva Pharmaceutical Industries Ltd Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. TEVA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.

TEVA stock price ended at $16.96 on Friday, after rising 0.12%

The Teva Pharmaceutical Industries Ltd stock price increased by 0.12% on the last trading day (23 May 2025), rising from 16.57 to 16.96. Throughout the last trading session, the stock experienced a fluctuation of 3.20% , ranging from a day low of $16.55 to a day high of 17.08. The price has declined in 5 of the last 10 days, resulting in a total change of 0.18% during this period. On the last day, trading volume decrease by -1.21M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 6.48M  shares were traded, amounting to approximately 109.30M.

TEVA Technical Signals

TEVA(Teva Pharmaceutical Industries Ltd Corp) has 4 buy signals and 0 sell signals now. The current trend is consolidation starting from 2025-05-08. The total price change during this trend is -6.14%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of TEVA over the last 5 trading days is 140.10M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.

TEVA Moving Average Analysis

Teva Pharmaceutical Industries Ltd's overall moving average trend leans more bullish as of Saturday, May 24, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $18.205996666666664, and $18.849666666666664. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $16.123336666666667, and $15.479666666666667. A break-down below any of these levels will issue sell signals.

TEVA Short Selling Analysis

The short sale ratio of Teva Pharmaceutical Industries Ltd(TEVA) as of 16 May 2025 is 24.46%, rising from last trading day. With increasing price from 16.87 to 16.94. The short sell activity indicate that short sellers may be anticipating a price reversion.

Technical Signal

Technical Signals Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
0
Buy
4

Moving Average

Swing

up ImagePositive

Stock Price Above SMA_5

Short Term

up ImagePositive

SMA_5 Above SMA_20

Mid Term

up ImagePositive

SMA_20 Above SMA_60

Long Term

down ImageNegative

SMA_60 Below SMA_200

Short Selling

Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 > 0

1.343

Bullish

Momentum (10 days)

MOM_10 > 0

0.03

Bullish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 > 0

0.462

Bullish

Stochastic RSI %K (14, 14, 3, 3)

STOCHRSIk_14_14_3_3 < 20

10.78

Bullish
0 Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data

TEVA Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to Teva Pharmaceutical Industries Ltd(TEVA), our algorithm predicts TEVA's 1-month price at $26.81, with an 58.26%upwardshift. Using a similarity score up to 98.35%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Teva Pharmaceutical Industries Ltd (TEVA.N) stock, as of Sunday, May 18, 2025 , forecasts a 58.26% change over the next month, based on its high correlation with XXII.O stock patterns. The similarity between their price movements over the analyzed periods is 98.35%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
stocks logo

TEVA

No Data
stocks logo

XXII

Up: 58.26%Similarity: 98.35%

Name

Similarity

Up/Down

stocks logo

XXII.O

98.35%

+58.26%

stocks logo

EBR.B.N

97.96%

+6.50%

stocks logo

ACR.N

97.93%

-0.10%

stocks logo

FENC.O

97.91%

-18.44%

stocks logo

SCOR.O

97.91%

+7.30%

stocks logo

DECK.N

97.89%

-9.73%

stocks logo

AZZ.N

97.88%

-2.04%

stocks logo

CIB.N

97.81%

-13.63%

stocks logo

HII.N

97.81%

-4.08%

stocks logo

FPH.N

97.80%

-5.64%

TEVA Seasonality Analysis

Based on TEVA's historical stock price data across all years, the probability of a positive return in May is45.45%, suggesting it maynotbe an ideal month to invest in TEVA. In contrast,Januaryoffers the highest probability of positive returns at63.64%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in January has the highest probability of a positive return (63.64%), while August has the lowest probability (20.00%).

Performance Seasonality

The chart shows Teva Pharmaceutical Industries Ltd. (TEVA)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.

People Also Watch

FAQ

arrow icon

Should I buy Teva Pharmaceutical Industries Ltd (TEVA.N) stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. TEVA has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
arrow icon

Which months have the highest win rate for buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in a year?

The radar chart shows that buying Teva Pharmaceutical Industries Ltd (TEVA.N) stock in January has the highest probability of a positive return (63.64%), while August has the lowest probability (20.00%).

arrow icon

How has Teva Pharmaceutical Industries Ltd. (TEVA)'s stock price performed over the past three years?

TEVA's stock price rose by 9.55% in 2023,increased by 106.56% in 2024, and went down by 20.38% in 2025.

arrow icon

Which bull technical signals does TEVA have?

Bullish technical signals of TEVA include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, STOCHRSIk_14_14_3_3 < 20.

arrow icon

Which bearish technical signals does TEVA have?

Bearish technical signals of TEVA include:

arrow icon

Is TEVA a buy based on overall technical signals summary?

TEVA has 4 buy signals and 0 sell signals now. Overall the technical rating for TEVA is Strong buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of TEVA.

arrow icon

What is the trend of Teva Pharmaceutical Industries Ltd (TEVA)'s moving average?

Teva Pharmaceutical Industries Ltd's overall moving average trend leans more bullish as of May 24 2025, with 1 negative signals and 3 positive signal.

arrow icon

What is price prediction for TEVA stock next month?

The price prediction chart for Teva Pharmaceutical Industries Ltd (TEVA.N) stock, as of May 18 2025, forecasts a 58.26% change over the next month, based on its high correlation with XXII stock patterns. The similarity between their price movements over the analyzed periods is 98.35%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

arrow icon

What is price prediction 2025 for TEVA Stock?

### **Price Prediction for TEVA Stock in 2025** Based on current trends and analysis, TEVA stock is expected to reach **$22 to $28** by the end of 2025. **Reasons for the Prediction:** 1. **Analyst Consensus**: B of A Securities recently raised its price target for TEVA to $22, reflecting confidence in the company's growth prospects. 2. **Strong Earnings and Guidance**: TEVA reported strong Q1 2025 earnings, beating estimates, and raised its full-year guidance, signaling improved profitability. 3. **Product Growth**: The company's branded drugs, such as Austedo, are driving revenue growth, while the generics business is stabilizing. 4. **Cost-Cutting Measures**: TEVA's $700 million cost-saving initiative is expected to enhance margins and support long-term growth. This prediction aligns with the company's "Pivot to Growth" strategy and improving financial health. {RATING:symbol=TEVA, type=0}

arrow icon

What is price prediction 2030 for TEVA Stock?

Teva Pharmaceutical Industries (TEVA) is expected to reach a stock price of **$35 by 2030**, driven by its strong branded product growth, stabilization of generics business, and successful debt reduction efforts. The company's "Pivot to Growth" strategy and cost-cutting initiatives position it well for long-term profitability. Analysts have set a near-term price target of **$23**, reflecting confidence in its current trajectory.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free